Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
10 Results Found
AHA Details Legislative Priorities for Congressional Leaders
Hospitals and health systems are experiencing significant financial pressures that challenge their ability to provide 24/7 care for the patients and communities they serve. As Congress begins to focus on its end-of-the-year work, America’s hospitals and health systems respectfully request that you consider the following priorities.
AHA, Others File Brief in Missouri to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements
The American Hospital Association, 340B Health, and the American Society of Health-System Pharmacists (collectively, the “Proposed Amici”) respectfully move this Court for leave to file the attached amicus curiae brief in support of Defendants Attorney General Andrew Bailey, President of the Missouri Board of Pharmacy James L. Gray, Vice President of the Missouri Board of Pharmacy Christian S. Tadrus, and Members of the Missouri Board of Pharmacy Douglas R. Lang, Colby Grove, Anita K. Parran, Tammy Thompson, and Darren Harris’s Motion to Dismiss and Opposition to Plaintiff Novartis Pharmaceuticals Corporation’s Motion for Preliminary Injunction (Exhibit A).
Senators seek stakeholder feedback on draft 340B legislation
A bipartisan group of senators Feb. 2 released for stakeholder feedback a discussion draft of legislation to clarify in statute Congress’ intent for the 340B program to help safety net providers maintain, improve and expand patient access to health care services by requiring drug manufacturers that participate in Medicaid and Medicare Part B to provide discounts and rebates to covered entities that serve a disproportionate share of low-income and underserved patients.
AHA 340B Advocacy Alliance Bulletin - March 20, 2023
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National Association of Community Health Centers and other groups to remove many hospitals, eligible drugs and patients from the 340B program “would only save drug company profits by reducing their already modest financial contribution to the health care safety net,” the AHA and other national hospital groups said in a statement today.
Golden Valley Memorial Healthcare | Missouri
Golden Valley Memorial Healthcare (GVMH) has served the people of Missouri for over 50 years. Based in Clinton, Missouri, GVMH is the only hospital serving three rural counties between Kansas City and Springfield, covering an 80-mile radius.
AHA 340B Advocacy Alliance Bulletin - July 22, 2022
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system rates by a net 2.7% in calendar year 2023 compared to 2022.
Advancing Health in America Is a Bipartisan Goal We Can All Get Behind
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment.
340B Advocacy Alliance Bulletin: Updates on 340B Legislation, Representatives Letter to HHS
Updates on 340B Legislation, Representatives Letter to HHS
Speak Up, Be Heard and Exercise Your Right to Vote
Forty-six days from now on Nov. 8 millions of Americans will cast their ballots and exercise their most sacred right – the right to vote.
Deadline Extended Until Oct. 29 for Your Representatives to Sign ‘Dear Colleague’ Letter Urging HHS to Take Action
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Department of Health and Human Services Secretary Alex Azar expressing concern about recent efforts by Kalderos to transition the 340B Drug Pricing Program from one of up-front discounts to post-sale rebates.